Brough; Stephen
Patent Applications and Registrations
Patent applications and USPTO patent grants for Brough; Stephen.The latest application filed is for "pyrazinone derivatives".
- Brough; Stephen - Cheshire GB
- Brough; Stephen - Leicestershire N/A GB
- Brough; Stephen - Macclesfield GB
- Brough; Stephen - Loughborough GB
- Brough; Stephen - Selston GB
- Brough; Stephen - Notts GB
| Patent | Date |
|---|---|
| Pyrazinone Derivatives App 20150073136 - Brough; Stephen ; et al. | 2015-03-12 |
| 9-substituted 8-oxoadenine compound Grant 8,969,362 - Kurimoto , et al. March 3, 2 | 2015-03-03 |
| Pyrazinone derivatives, pharmaceutically acceptance salts thereof and their uses Grant 8,889,692 - Brough , et al. November 18, 2 | 2014-11-18 |
| 9-Substituted 8-Oxoadenine Compound App 20140045837 - Kurimoto; Ayumu ; et al. | 2014-02-13 |
| 9-substituted 8-oxoadenine compound Grant 8,575,180 - Kurimoto , et al. November 5, 2 | 2013-11-05 |
| Pyrazinone Derivatives, Pharmaceutically Acceptable Salts Thereof And Their Uses App 20130012523 - Brough; Stephen ; et al. | 2013-01-10 |
| N-cyclopropyl-3-fluoro-5-[3-[[1-[2-[2- [(2-hydroxethyl)amino] ethoxy]phenyl] cyclopropyl] amino]-2-oxo-1 (2H)-pyrazinyl]-4-methyl-benzamide, or pharmaceutically acceptable salts thereof and their uses Grant 8,299,246 - Brough , et al. October 30, 2 | 2012-10-30 |
| N-cyclopropyl-3-fluoro-5-[3-[[1-[2-[2- [(2-hydroxethyl)amino] Ethoxy]phenyl] Cyclopropyl] Amino]-2-oxo- 1 (2h)-pyrazinyl]-4-methyl-benzamide, Or Pharmaceutically Acceptable Salts Thereof And Their Uses App 20120214822 - Brough; Stephen ; et al. | 2012-08-23 |
| Compounds and their uses 708 Grant 8,163,905 - Brough , et al. April 24, 2 | 2012-04-24 |
| Compounds Grant 8,158,820 - Bonnert , et al. April 17, 2 | 2012-04-17 |
| Compounds And Their Uses 708 App 20120065214 - BROUGH; Stephen ; et al. | 2012-03-15 |
| 9-substituted 8-oxoadenine Compound App 20110306610 - KURIMOTO; Ayumu ; et al. | 2011-12-15 |
| 9-substituted 8-oxoadenine compound Grant 8,012,964 - Kurimoto , et al. September 6, 2 | 2011-09-06 |
| Novel Compounds App 20110166117 - Bonnert; Roger ; et al. | 2011-07-07 |
| Substituted thiophene compounds App 20090181962 - Baxter; Andrew ; et al. | 2009-07-16 |
| Purine Derivatives For The Treatment Of Viral Or Allergic Diseases And Cancers App 20090082332 - Abbot; Philip ; et al. | 2009-03-26 |
| Substituted Thiophene compounds Grant 7,358,376 - Baxter , et al. April 15, 2 | 2008-04-15 |
| 9-Substituted 8-oxoadenine compound App 20070190071 - Kurimoto; Ayumu ; et al. | 2007-08-16 |
| Substituted indoles Grant 7,166,607 - Bonnert , et al. January 23, 2 | 2007-01-23 |
| Novel compounds App 20060264435 - Bonnert; Roger ; et al. | 2006-11-23 |
| Chemical compounds Grant 6,958,350 - Brough , et al. October 25, 2 | 2005-10-25 |
| Compounds Grant 6,946,478 - Baxter , et al. September 20, 2 | 2005-09-20 |
| Novel substituted indoles App 20050165055 - Bonnert, Roger ; et al. | 2005-07-28 |
| Chemical compounds App 20040102483 - Brough, Stephen ; et al. | 2004-05-27 |
| Novel compounds App 20030134840 - Baxter, Andrew ; et al. | 2003-07-17 |
| Compounds Grant 6,518,286 - Baxter , et al. February 11, 2 | 2003-02-11 |
| Novel Compounds App 20020107252 - Baxter, Andrew ; et al. | 2002-08-08 |
| Adamantane derivatives Grant 6,242,470 - Baxter , et al. June 5, 2 | 2001-06-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 